<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02078583</url>
  </required_header>
  <id_info>
    <org_study_id>PEKING SEDATION</org_study_id>
    <nct_id>NCT02078583</nct_id>
  </id_info>
  <brief_title>The Effect of Analgesia Based Sedation Protocol on Brain Function of Critical Care Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University People's Hospital</source>
  <brief_summary>
    <textblock>
      Benzodiazepines is a commonly uesd sedative medication,there are many reports that
      Benzodiazepines is associated with delirium ,but using of analgesia reduces benzodiazepines
      requirements .The purpose of this study is to determine whether analgesia based sedation
      protocol reduces the incident of delirium.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>July 2014</start_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence and duration of delirium in patients with different regimens</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilator-free days</measure>
    <time_frame>an expected average of 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean days of mechanical ventilation</measure>
    <time_frame>an expected average of 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of ICU stay</measure>
    <time_frame>an expected average of 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Index of anesthesia depth monitoring</measure>
    <time_frame>From admission to ICU to weaning,about 7 days</time_frame>
    <description>Analgesic level、sedation level、brain function、 blood perfusion for peripheral and brain circulation、sleep stages and variation of blood volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infusion velocity and total dose of sedative drugs in different groups</measure>
    <time_frame>From admission to ICU to extubation or drug withdrawal,about 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma melatonin level</measure>
    <time_frame>Every 6 hours during the next ICU day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total rescue dose of midazolam</measure>
    <time_frame>Seven days after giving midazolam to patient</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variations of HR、RR、BP、SpO2</measure>
    <time_frame>an expected average of 7 days</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Delirium</condition>
  <arm_group>
    <arm_group_label>Remifentanil，midazolam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Remifentanil 1µg/kg/hr intravenous pump and Midazolam loading dose 0.05mg/kg followed by 0.02~0.1mg/kg/h continuous intravenous pump for 7days or extubation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fentanyl，midazolam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fentanyl 1µg/kg/hr intravenous pump and Midazolam loading dose 0.05mg/kg followed by 0.02~0.1mg/kg/h continuous intravenous pump for 7days or extubation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal saline1µg/kg/hr intravenous pump and Midazolam loading dose 0.05mg/kg followed by 0.02~0.1mg/kg/h continuous intravenous pump for 7days or extubation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <arm_group_label>Fentanyl，midazolam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <arm_group_label>Remifentanil，midazolam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <arm_group_label>Normal saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signing a consent form

          -  postoperative patient

          -  Requirement for mechanical ventilation and anticipate time of mechanical ventilation
             more than 24 hours

          -  Requirement for sedation

          -  Age more than 18 and less than 85 years old

        Exclusion Criteria:

          -  Unstable blood circulation

          -  Heart rate less than 50 beats per minute

          -  II ° ～ III ° atrioventricular conduct block

          -  Intracranial lesions 、neurosurgical intervention and mental disability inability to
             cooperate;

          -  Receipt of antipsychotics 、hypnotic drugs before surgery ;

          -  Alcohol abuse;

          -  Liver failure class Child-Pugh C;

          -  Acute Respiratory Distress Syndrome;

          -  Acute or chronic renal failure;

          -  Other severe diseases ,septic shock;

          -  Receipt of neuromuscular blocking drug;

          -  Pregnancy and nursing woman;

          -  Allergy to investigational drug or other contraindication.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Dan Liu, Resident physician</last_name>
    <phone>+8613811365572</phone>
    <email>fancyjuice@126.com</email>
  </overall_contact>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 28, 2014</study_first_submitted>
  <study_first_submitted_qc>March 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2014</study_first_posted>
  <last_update_submitted>July 15, 2014</last_update_submitted>
  <last_update_submitted_qc>July 15, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 16, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

